AAHA Conference 2016: Join us AT THE INTERSECTION of Human Science and Veterinary Medicine
Attend our Emerging Therapeutic Technologies CE sessions on Friday, April 1 and our Sunrise Session with breakfast on Saturday, April 2 to discover unique therapeutics in development for osteoarthritis and post-operative pain management, inappetence and osteosarcoma at the American Animal Hospital Association Conference 2016. Our sessions schedule includes four educational discussions presented by six different speakers.
These scientific presentations include new therapeutics that we anticipate will receive approval in 2016 and beyond, including GALLIPRANT® (grapiprant tablets), which was recently approved by the U.S. Food and Drug Administration Center for Veterinary Medicine for the control of pain and inflammation associated with osteoarthritis in dogs. You’ll be inspired by the connections we’re making between human science and veterinary medicine, as we work to help veterinarians raise the standard of care for our pets.
The informational programs on Friday morning will be held in Room 19A in the Austin Convention Center. The Sunrise Session on Saturday will be held in the Grand Ballroom Salon J in the Austin Hilton and includes breakfast with doors opening at 6:30 a.m. Plan to arrive early to get your seat!
Plan to also connect with us at the Aratana booth #311 to learn more about our mission of developing safe and effective therapeutics for unmet or underserved medical needs in pets.
Find out how you could win a FREE Apple Watch when you come to our booth.*
*NO PURCHASE NECESSARY. Must be 21 years of age and a licensed veterinarian or veterinary technician to be eligible to win. Void where prohibited. See official rules at the Aratana Therapeutics booth #311.
IMPORTANT SAFETY INFORMATION
GALLIPRANT® (grapiprant tablets) is for use in dogs only. Do not use in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, or in pregnant or lactating dogs. Adverse reactions in dogs may include mild gastrointestinal effects including, vomiting, diarrhea and decreased appetite. Should not be used in dogs that have a hypersensitivity to grapiprant. Avoid use with COX-inhibiting NSAIDs or corticosteroids. Please see the full Prescribing Information.